Pfizer CEO Albert Bourla on Covid-19 vaccine manufacturing outlook
Pfizer CEO Albert Bourla told CNBC’s “Squawk Box” Tuesday that the company plans to increase coronavirus vaccine production this year,
Read morePfizer CEO Albert Bourla told CNBC’s “Squawk Box” Tuesday that the company plans to increase coronavirus vaccine production this year,
Read moreA coronavirus vaccine developed by Pfizer and BioNTech appears to be effective against a key mutation in the more infectious
Read moreJohnson & Johnson has begun its phase three trial testing its potential coronavirus vaccine, the pharmaceutical company announced Wednesday. CNBC’s
Read moreModerna should have enough data from its late-stage trial to know whether its coronavirus vaccine works in November, CEO Stephane
Read moreDr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins “Squawk Box”
Read moreThe U.S. government has awarded Novavax $1.6 billion to support the late-stage development and scale up in manufacturing of its
Read moreWhite House health advisor Dr. Anthony Fauci said he worries about the “durability” of a potential coronavirus vaccine, saying there’s
Read moreAmid Monday’s sell-off, the biotech sector seemed to fare well on prospects of a coronavirus treatment. Jared Holz, health-care equity
Read moreDr. Robin Shattock, head of mucosal infection and immunity at the Department of Medicine at Imperial College London, joins “Squawk
Read moreSky News reported Wednesday morning that a British scientist has made a breakthrough in the race for a coronavirus vaccine.
Read more